Mira Pharmaceuticals reports new preclinical data on Mira-55

June 25, 2026 8:15 AM

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) announced new preclinical pharmacology data showing that its cannabinoid analog Mira-55 displays a distinct mechanism ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found